[Phe1Ψ(CH2-NH)Gly2]nociceptin-(1-13)-NH2 activation of an inward rectifier as a partial agonist of ORL1 receptors in rat periaqueductal gray

British Journal of Pharmacology

Volumn 128, Issue 1, 1999, Pages 103-107

  Chiou, Lih Chu ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Phe1 (CH2 NH)Gly2 nociceptin (1 13) NH2; Brain slices; K+ channels; ORL1; Orphanin FQ nociceptin; Patch clamp; Periaqueductal gray

Indexed keywords

NOCICEPTIN; OPIATE RECEPTOR; PARTIAL AGONIST; POTASSIUM CHANNEL; POTASSIUM ION; INWARDLY RECTIFYING POTASSIUM CHANNEL; NOCICEPTIN (1 13) NH2, PHE(1) PSI(CH2 NH) GLY(2); NOCICEPTIN (1-13)-NH2, PHE(1)-PSI(CH2-NH)-GLY(2)-; NOCICEPTIN RECEPTOR; OPIATE PEPTIDE; PEPTIDE FRAGMENT; POTASSIUM;

ANALGESIA; ANIMAL TISSUE; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG EFFICACY; HYPERALGESIA; MEMBRANE CURRENT; NEWBORN; NONHUMAN; PATCH CLAMP; PERIAQUEDUCTAL GRAY MATTER; POTASSIUM CONDUCTANCE; PRIORITY JOURNAL; RAT; THALAMUS VENTRAL NUCLEUS; ANIMAL; CELL MEMBRANE POTENTIAL; COMPARATIVE STUDY; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ELECTRIC CONDUCTIVITY; IN VITRO STUDY; METABOLISM; NERVE CELL; PHYSIOLOGY; TIME; WISTAR RAT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC CONDUCTIVITY; MEMBRANE POTENTIALS; NEURONS; OPIOID PEPTIDES; PATCH-CLAMP TECHNIQUES; PEPTIDE FRAGMENTS; PERIAQUEDUCTAL GRAY; POTASSIUM; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RATS; RATS, WISTAR; RECEPTORS, OPIOID; TIME FACTORS;

EID: 0032589310     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702746     Document Type: Article

References (33)

1. Anton, B., Fein, J., To, T., Li, X., Silberstein, L. & Evans, C.J. (1996). Immunohistochemical localization of ORL-1 in the central nervous system of the rat. J. Comp. Neurol., 368, 229-251.
2. Behbehani, M.M. (1995). Functional characteristics of the midbrain periaqueductal gray. Prog. Neurobiol., 46, 575-605.
3. Blanton, M.G., Loturco, J.J. & Kriegstein, A.R. (1989). Whole cell recording from neurons in slices of reptilian and mammalian cerebral cortex. J. Neurosci. Meth., 30, 203-210.
4. 2 is an agonist of the nociceptin (ORL1) receptor. Eur. J. Pharmacol., 349, R5-R6.
5. Calo, G., Rizzi, A., Marzola, G., Guerrini, R., Salvadori, S., Beani, L., Regoli, D. & Bianchi, C. (1998). Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay. Br. J. Pharmacol., 125, 373-378.
6. 2, a peripheral ORL-1 receptor antagonist, act as an agonist in the rat spinal cord. Br. J. Pharmacol., 125, 949-951.
7. Chiou, L.C. & Huang, L.-Y.M (1999). Mechanism underlying increased neuronal activity in the rat ventrolateral periaqueductal gray by a μ-opioid. J. Physiol., (in press).
8. Chu, X., Xu, N., Li, P. & Wang, J.Q. (1999). The nociceptin receptor-mediated inhibition of the rat rostral ventrolateral medulla neurons in vitro. Eur. J. Pharmacol., 364, 49-53.
9. 2+ channel currents of acutely dissociated rat periaqueductal gray neurons. J. Physiol., 509, 47-58.
10. Darland, T., Heinricher, M.M. & Grandy, D.K. (1998). Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more. Trends Neurosci., 21, 215-221.
11. Gintzler, A.R., Adapa, I.D., Toll, L., Medina, V.M. & Wang, L. (1997). Modulation of enkephalin release by nociceptin (orphanin FQ). Eur. J. Pharmacol., 325, 29-34.
12. 2 acts as an agonist of the orphanin FQ/nociceptin receptor in vivo. Eur. J. Pharmacol., 357, R1-R3.
13. Guerrini, R., Calo, G., Rizzi, A., Bigoni, R., Bianchi, C., Salvadori, S. & Regoli, D. (1998). A new selective antagonist of the nociceptin receptor. Br. J. Pharmacol., 123, 163-165.
14. 2 and orphanin FQ/nociceptin (OFQ/N) produce similar cardiovascular and renal responses in conscious rats. J. Pharmacol. Exp. Ther., 289, 173-180.
15. Mathis, J.P., Ryan-Moro, J., Chang, A., Hom, J.S.H., Scheinberg, D.A. & Pasternak, G.W. (1997). Biochemical evidence for orphanin FQ/nociceptin receptor heterogeneity in mouse brain. Biochem. Biophy. Res. Comm., 230, 462-465.
16. Meis, S. & Pape, H.-C. (1998). Postsynaptic mechanisms underlying responsiveness of amygdaloid neurons to nociceptin/orphanin FQ. J. Neurosci., 15, 8133-8144.
17. Meunier, J.C., Mollereau, C., Toll, L., Suaudeau, C., Moisand, C., Alvineril:, P., Butour, J.L., Guillemot, J.-C., Ferrara, P., Monsarrat, B., Mazarguil, H., Vassart, G., Parmentier, M. & Costentin, J. (1995). Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature, 377, 532-535.
18. Mollereau, C., Parmentier, M., Mailleux, P., Butour, J.L., Moisand, C., Chalon, P., Caput, D., Vassart, G. & Meunier, J.C. (1994). ORL1, a novel member of the opioid receptor family: cloning, functional expression and localization. FEBS Lett., 341, 33-38.
19. Monteilletagius, G., Fein, J., Anton, B. & Evans, C.J. (1998). URL-1 and mu opioid receptor antisera label different fibers in areas involved in pain processing. J. Comp. Neurol., 399, 373 383.
20. Montiel, J.-C, Cornille, F., Roques, B.P. & Noble, F. (1997). Nociceptin/orphanin FQ metabolism: role of aminopeptidase and endopeptidase 24.15. J. Neurochem., 68, 354-361.
21. Morgan, M.M., Grisel, J.E., Robbins, C.S. & Grandy, D.K. (1997). Antinociception mediated by the periaqueductal gray is attenuated by orphanin. Neuroreport, 8, 3431-3434.
22. Neher, E. (1992). Correction for liquid junction potentials in patch clamp experiments. Methods Enzymol., 207, 123-131.
23. Nothacker, H.P., Reinscheid, R.K., Mansour, A., Henningsen, R.A., Ardati, A., Monsma, F.J., Watson, S.J. & Civelli, O. (1996). Primary structure and tissue distribution of the orphanin FQ precursor. Proc. Natl. Acad. Sci. U.S.A., 93, 8677-8682.
24. Osborne, P.B., Vaughan, C.W., Wilson, H.I. & Christie, M.J. (1996). Opioid inhibition of rat periaqueductal grey neurons with identified projections to rostral ventromedial medulla in vitro. J. Physiol., 490, 383-38.
25. Reinscheid, R.K., Nothacker, H.-P., Bourson, A., Ardati, A., Henningsen, R.A., Bunzow, J.R., Grandy, D.K., Langen, H., Monsma, F.J. & Civelli, O. (1995). Orphanin FQ: a novel neuropeptide that is a natural ligand of an opioid-like G protein-coupled receptor. Science, 270, 792-764.
26. Rossi, G.C., Perlmutter, M., Leventhal, L., Talatti, A. & Pasternak, G.W. (1998). Orphanin FQ/nociceptin analgesia in the rat. Brain Res., 792, 327-330.
27. Schlicker, E., Werthwein, S., Kathmann, M. & Bauer, U. (1998). Nociceptin inhibits noradrenaline release in the mouse brain cortex via presynaptic ORL1 receptors. Naunyn-Schmied. Arch. Pharmacol., 358, 418-422.
28. Schulz, S., Schreff, M., Nuß, D., Gramsch, C. & Hollt, V. (1996). Nociceptin/orphanin FQ and opioid peptides show overlapping distribution but not co-localization in pain-modulatory brain regions. Neuroreport, 7, 3021-3025.
29. Shaii, S., Page, C.P. & Spina, D. (1998). Nociceptin inhibits non-adrenergic non-cholinergic contraction in guinea-pig airway. Br. J. Pharmacol., 125, 510-516.
30. Vaughan, C.W. & Christie, M.J. (1997). Presynaptic inhibitory action of opioids on synaptic transmission in the rat periaqueductal grey in vitro. J. Physiol., 498, 463-472.
31. Vaughan, C.W., Ingram, S.L. & Christie, M.J. (1997). Actions of the ORL, receptor ligand nociceptin on membrane properties of rat periaqueductal gray neurons in vitro. J. Neurosci., 17, 996-1003.
32. 2, a proposed antagonist of the nociceptin receptor, is a potent and stable agonist in the rat spinal cord. Neurosci. Lett., 249, 127-130.
33. Yaksh, T.L., Yeung, J.C. & Rudy, T.A. (1976). Systematic examination in the rat of brain sites sensitive to the direct application of morphine: obervation of differential effects within the periaqeductal gray. Brain Res., 114, 83-103.